Shree Signify Exim Private Limited

Brand Names: Lenalid, Revlimid (widely known brand based on composition)

Composition: Lenalidomide 15 mg

Strength: 15 mg

Manufacturer: Natco Pharma Ltd.

Packaging: Typically available in blister packs containing 10 capsules

Treatment: Multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma

Product Description:
Lenalid 15 Capsule contains Lenalidomide, an immunomodulatory agent that is primarily used in the treatment of certain types of cancers, including multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma. Lenalidomide works by affecting the immune system to inhibit the growth of cancer cells, promote the destruction of abnormal cells, and reduce the formation of blood vessels that supply tumors.

Common indications for Lenalid 15 Capsule include:

• Multiple Myeloma: Used in combination with other medications to treat multiple myeloma, particularly in patients who have received at least one prior therapy.
• Myelodysplastic Syndromes (MDS): Used to treat certain types of MDS, especially in patients with a specific chromosomal abnormality.
• Mantle Cell Lymphoma: Used in patients whose disease has relapsed or progressed after two prior therapies, including bortezomib.

Dosage and Administration:

• For Adults: The dosage of Lenalid 15 Capsule varies depending on the condition being treated. The exact dosage regimen should be determined by a healthcare provider based on individual patient factors and response to treatment.
• Administration: The capsule should be swallowed whole with water, with or without food. It is important to follow the prescribed schedule and not to break, chew, or open the capsules.

Common side effects of Lenalid 15 Capsule may include:

• Fatigue
• Anemia
• Neutropenia (low white blood cell count)
• Thrombocytopenia (low platelet count)
• Diarrhea
• Rash

Due to the risk of serious side effects, including birth defects, Lenalidomide is subject to special safety monitoring and prescribing programs. Patients should discuss all potential risks and benefits with their healthcare provider.

Packaging:
Lenalid 15 Capsule is typically packaged in blister packs containing 10 capsules, providing a convenient form for daily or cyclical use as prescribed by a healthcare provider.

Lenalid 15 Capsule is a critical medication in the management of certain hematological cancers, offering a targeted approach to treatment that leverages the body's immune system to fight disease. Its use in conditions like multiple myeloma and MDS has significantly improved outcomes for many patients, though it requires careful monitoring and adherence to prescribed safety protocols.

Brand Names: Palnat, Ibrance (widely known brand based on composition)

Composition: Palbociclib 125 mg

Strength: 125 mg

Manufacturer: Natco Pharma Ltd.

Packaging: Typically available in blister packs containing 21 capsules

Treatment: Breast cancer (hormone receptor-positive, HER2-negative)

Product Description:
Palnat 125 Capsule contains Palbociclib, a targeted cancer therapy known as a cyclin-dependent kinase (CDK) 4/6 inhibitor. It is used in combination with hormonal therapies to treat hormone receptor-positive, HER2-negative breast cancer. Palbociclib works by inhibiting the activity of CDK4 and CDK6, which are enzymes that promote cell division. By blocking these enzymes, Palbociclib slows the growth and spread of cancer cells.

Common indications for Palnat 125 Capsule include:

• Breast Cancer: Used in combination with an aromatase inhibitor as the first-line treatment of hormone receptor-positive, HER2-negative advanced or metastatic breast cancer in postmenopausal women. It is also used with fulvestrant in patients whose disease has progressed after endocrine therapy.

Dosage and Administration:

• For Adults: The recommended dose is 125 mg taken orally once daily for 21 consecutive days, followed by 7 days off treatment, making up a 28-day cycle.
• Administration: The capsule should be swallowed whole with water, preferably with food. It should not be chewed, crushed, or opened.

Common side effects of Palnat 125 Capsule may include:

• Neutropenia (low white blood cell count)
• Fatigue
• Nausea
• Diarrhea
• Infections
• Stomatitis (inflammation of the mouth)
• Thrombocytopenia (low platelet count)

Patients are advised to undergo regular blood tests to monitor blood cell counts during treatment, as well as to report any signs of infection or unusual symptoms to their healthcare provider immediately.

Packaging:
Palnat 125 Capsule is typically packaged in blister packs containing 21 capsules, which corresponds to one cycle of treatment.

Palnat 125 Capsule is an important medication in the treatment of advanced breast cancer, offering a targeted approach that, when used in combination with hormonal therapies, can help control the disease and improve survival outcomes. Adherence to the prescribed regimen and regular monitoring are essential to maximize the benefits of this therapy while managing potential side effects.

Product Name: Biovorin 15mg Tablet

Brand Name: Biovorin, Leucovorin, Folinic

Composition: Calcium Leucovorin / Calcium Folinate (15mg)

Manufacturer/Marketer: Zydus Cadila

Packaging: To be provided (specify packaging details if available)

Treatment: Methotrexate toxicity, megaloblastic anemia, colorectal cancer (as adjuvant therapy)

Product Description: Biovorin 15mg Tablet contains Calcium Leucovorin (Calcium Folinate), a medication used to reduce the harmful effects of methotrexate in cancer therapy, treat megaloblastic anemia due to folic acid deficiency, and enhance the efficacy of fluorouracil in colorectal cancer treatment. It works by replenishing folate levels and protecting healthy cells from damage

Product Name: Tucanat 150 Tablet

Brand Name: Tucanat, Tukysa, Tuksan

Composition: Tucatinib (150mg)

Manufacturer/Marketer: Natco Pharma Ltd

Packaging: To be provided (specify packaging details if available)

Treatment: HER2-positive breast cancer (advanced or metastatic)

Product Description: Tucanat 150 Tablet contains Tucatinib, a tyrosine kinase inhibitor used in the treatment of advanced or metastatic HER2-positive breast cancer. Often used in combination with other therapies like trastuzumab and capecitabine, it works by selectively inhibiting the HER2 signaling pathway, slowing cancer cell growth and spread

Brand Names: Tagrisso (widely known brand based on composition)

Composition: Osimertinib

Strength: 80 mg

Manufacturer: AstraZeneca

Packaging: Typically available in a pack of 30 tablets

Treatment: Non-small cell lung cancer (NSCLC) with specific epidermal growth factor receptor (EGFR) mutations

Product Description:
Tagrisso 80mg Tablet contains Osimertinib, a targeted cancer therapy used in the treatment of non-small cell lung cancer (NSCLC) that has specific mutations in the epidermal growth factor receptor (EGFR). Osimertinib is an EGFR tyrosine kinase inhibitor (TKI) that works by blocking the activity of the mutated EGFR, which drives the growth and spread of cancer cells. It is particularly effective against NSCLC that has developed resistance to other EGFR inhibitors.

Common indications for Tagrisso 80mg Tablet include:

• Cancer Treatment: Used in the management of non-small cell lung cancer (NSCLC) with specific EGFR mutations.

Dosage and Administration:

• For Adults: The typical dose is one 80 mg tablet taken orally once daily. The exact dosage and duration of treatment are determined by the oncologist based on the patient's condition and response to therapy.
• Administration: Tagrisso should be taken with or without food, and at the same time each day.

Common side effects of Tagrisso 80mg Tablet may include:

• Diarrhea
• Rash
• Dry skin
• Stomatitis (inflammation of the mouth)
• Nail changes

Serious side effects can include interstitial lung disease, QT prolongation (a type of heart rhythm problem), and low blood cell counts. Regular monitoring of lung function, heart function, and blood tests is essential during treatment.

Packaging:
Tagrisso 80mg Tablet is typically packaged in a box containing 30 tablets, with each tablet individually sealed to ensure proper dosage and patient safety.

Tagrisso 80mg Tablet is a vital medication in the treatment of non-small cell lung cancer (NSCLC) with specific EGFR mutations. It offers a targeted approach that can significantly improve outcomes for patients with this type of cancer. However, due to its potential for serious side effects, it should be used under the guidance and supervision of an experienced oncologist. Regular monitoring of patient health and response to therapy is crucial during treatment with Osimertinib.

Brand Names: Bracanat, Lynparza (widely known brand based on composition)

Composition: Olaparib 150 mg

Strength: 150 mg

Manufacturer: Natco Pharma Ltd.

Packaging: Typically available in blister packs containing 14 tablets

Treatment: Ovarian cancer, breast cancer, pancreatic cancer, prostate cancer

Product Description:
Bracanat 150mg Tablet contains Olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor used in the treatment of various cancers, particularly those associated with BRCA gene mutations. Olaparib works by blocking the PARP enzyme, which helps repair damaged DNA in cells. By inhibiting this enzyme, Olaparib prevents cancer cells from repairing themselves, leading to their death.

Common indications for Bracanat 150mg Tablet include:

• Ovarian Cancer: Used in the maintenance treatment of adult patients with advanced ovarian cancer who have responded to first-line platinum-based chemotherapy.
• Breast Cancer: Used in the treatment of HER2-negative breast cancer with BRCA1/2 mutations.
• Pancreatic Cancer: Used in the maintenance treatment of BRCA-mutated metastatic pancreatic cancer.
• Prostate Cancer: Used in the treatment of metastatic castration-resistant prostate cancer with BRCA1/2 mutations.

Dosage and Administration:

• For Adults: The usual recommended dose is 300 mg (two 150 mg tablets) taken orally twice daily, for a total daily dose of 600 mg.
• Administration: The tablet should be swallowed whole with water, taken at approximately the same times each day, with or without food. It should not be crushed, chewed, or split.

Common side effects of Bracanat 150mg Tablet may include:

• Nausea
• Fatigue
• Anemia
• Vomiting
• Diarrhea
• Loss of appetite

Regular blood tests and monitoring are essential during treatment to manage potential side effects and adjust the dosage as needed.

Packaging:
Bracanat 150mg Tablet is typically packaged in blister packs containing 14 tablets, designed for a one-week course of treatment when taken as prescribed.

Bracanat 150mg Tablet is a significant advancement in cancer treatment, offering targeted therapy for patients with specific genetic mutations. It plays a crucial role in extending survival and improving the quality of life for patients with certain types of advanced cancers, particularly those associated with BRCA mutations. Regular monitoring and adherence to the prescribed regimen are vital to achieving the best possible outcomes.

Endace Tablets is used to treat breast cancer. We also have Anorest 40 mg Tablet manufacture by Natco LTD.

Revolade, Promacta Eltrombopag is used to treat thrombocytopenia (low platelets in the blood) in adults and children 1 year of age and older with a blood disorder called chronic idiopathic thrombocytopenic purpura (ITP). This medicine is used after a splenectomy (surgery to remove the spleen) and other medicines, such as steroids or immunoglobulin, have not worked well enough. Eltrombopag is also used to treat thrombocytopenia in patients with chronic hepatitis C, Platelets help clot the blood, so a person with thrombocytopenia may have bleeding problems. Eltrombopag works by stimulating the bone marrow to produce more platelets.

Eltrombopag is also used to treat severe aplastic anemia (SAA) in patients who have received other medicines to treat SAA, when those medications did not work well.

Erlonat is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.

Product Description:
Tretinoin CA Atra 10mg Softgel Capsules contain Tretinoin, a derivative of vitamin A, also known as all-trans retinoic acid (ATRA). This medication is used primarily in the treatment of acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia. Tretinoin works by promoting the differentiation of immature blood cells into normal cells, helping to restore normal blood cell production.

In addition to its use in treating APL, Tretinoin is also prescribed for the management of severe acne that has not responded to other treatments. It works by promoting skin cell turnover, reducing the formation of acne and unclogging pores.

Tretinoin softgel capsules are typically part of a combination therapy, particularly in APL treatment, and they are often used alongside other chemotherapy agents. Regular monitoring by a healthcare provider is essential during treatment, and it may take some time to observe the full therapeutic effects

• Kidney cancer

Rexigo 120mg tablet contains an active component called Relugolix, which belongs to a class of medicine called gonadotropin-releasing hormone (GnRH) receptor antagonists. It is used to treat adults with advanced hormone-sensitive prostate cancer. 

• Blood cancer (Chronic myeloid leukaemia)

• Abdominal pain
• Nausea
• Vomiting
• Diarrhea
• Headache
• Cough
• Low blood platelets
• Anemia (low number of red blood cells)
• Nasopharyngitis (inflammation of the throat and nasal passages)
• Respiratory tract infection
• Decreased white blood cell count (neutrophils)
• Breathlessness
• Increased liver enzymes

Product Description: Silofast 8mg Capsules contain Silodosin 8mg, a selective alpha-1 adrenergic receptor antagonist that is primarily used to treat symptoms of benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate gland in men. By relaxing the muscles in the prostate and bladder neck, Silodosin helps relieve symptoms such as difficulty in urination, a weak urine stream, and frequent or urgent urination, allowing smoother urine flow.

Silofast is highly effective in improving urinary symptoms and quality of life for men with BPH. It specifically targets the alpha-1A receptors in the prostate, minimizing the effect on blood pressure compared to other alpha-blockers. This makes it suitable for older patients or those with comorbidities.

Common side effects include dizziness, retrograde ejaculation (where semen enters the bladder instead of exiting through the penis), and a runny or stuffy nose. It is advised to take the capsule with food to reduce the risk of side effects, and patients should avoid operating heavy machinery or driving until they know how the medication affects them.

Silofast 8mg should be used under medical supervision, and patients are encouraged to consult their healthcare provider if they experience any severe side effects or if their symptoms do not improve. Regular follow-ups may be necessary to monitor the progression of BPH and the effectiveness of the treatment.

Brand Names: Tykerb

Composition: Lapatinib

Strength: 250 mg

Manufacturer: GlaxoSmithKline (GSK)

Packaging: Blister pack of 30 tablets

Treatment: HER2-Positive Breast Cancer

Product Description:
Tykerb 250 mg Tablet contains Lapatinib, a tyrosine kinase inhibitor used in the treatment of HER2-positive breast cancer. Lapatinib targets specific receptors involved in cancer cell growth, particularly the human epidermal growth factor receptor 2 (HER2) and epidermal growth factor receptor (EGFR). By inhibiting these receptors, Tykerb helps to slow down or stop the growth of cancer cells.

Common indications for Tykerb Tablet include:

• HER2-Positive Breast Cancer: Tykerb is used in combination with other medications, such as capecitabine or letrozole, to treat HER2-positive metastatic breast cancer that has not responded to previous therapies.

Dosage and Administration: The usual dosage of Tykerb is determined by the healthcare provider based on the patient’s specific condition and response to treatment. It is important to follow the prescribed dosage and administration schedule as directed.

Common side effects of Tykerb may include:

• Diarrhea
• Nausea
• Vomiting
• Fatigue
• Rash
• Liver enzyme abnormalities

More serious side effects can include potential cardiac issues, severe liver problems, and severe allergic reactions. Regular monitoring and follow-ups with the healthcare provider are essential to manage these potential risks and adjust the treatment as needed.

Packaging: Tykerb 250 mg is typically available in blister packs containing 30 tablets. This packaging helps ensure the medication's stability and allows for convenient dosing.

Tykerb is manufactured by GlaxoSmithKline (GSK), a leading pharmaceutical company known for its high-quality products. It offers a targeted therapy option for managing HER2-positive breast cancer, providing a critical tool for patients with this type of cancer. Regular consultations with healthcare professionals are important for monitoring the effectiveness of the therapy and managing any potential side effects.

Product Name: Temoside 100 Capsule

Brand Name: Temoside, Temodal, Temonat

Composition: Temozolomide (100mg)

Manufacturer/Marketer: Cipla Ltd

Packaging: Strip of 5 capsules

Treatment: Brain tumors (glioblastoma multiforme, anaplastic astrocytoma)

Product Description: Temoside 100 Capsule contains Temozolomide, an oral chemotherapy drug used in the treatment of certain types of brain tumors, such as glioblastoma multiforme and anaplastic astrocytoma. It works by slowing or stopping the growth of cancer cells

Product Name: Aprecap 125/80 Capsule

Brand Name: Aprecap, Emend, Aprepit

Composition: Aprepitant (125mg) + Aprepitant (80mg)

Manufacturer/Marketer: Glenmark Pharmaceuticals Ltd

Packaging: To be provided (specify packaging details if available)

Treatment: Prevention of nausea and vomiting caused by chemotherapy

Product Description: Aprecap 125/80 Capsule contains Aprepitant, a medication used to prevent nausea and vomiting associated with cancer chemotherapy. It works by blocking neurokinin-1 (NK1) receptors in the brain, which helps control the vomiting reflex triggered by chemotherapy treatments

Product Name: Cazanat 40 Tablet

Brand Name: Cazanat, Cabometyx, Cabozanib

Composition: Cabozantinib (40mg)

Manufacturer/Marketer: Natco Pharma Ltd

Packaging: To be provided (specify packaging details if available)

Treatment: Kidney cancer, liver cancer, thyroid cancer

Product Description: Cazanat 40 Tablet contains Cabozantinib, a targeted therapy medication used to treat advanced kidney, liver, and thyroid cancers. It works by inhibiting the growth of cancer cells by blocking specific proteins involved in tumor growth and angiogenesis, thereby reducing the spread of the disease

Product Name: Cytomid 250 Tablet

Brand Name: Cytomid, Flutax, Flutacan

Composition: Flutamide (250mg)

Manufacturer/Marketer: Cipla Ltd

Packaging: To be provided (specify packaging details if available)

Treatment: Prostate cancer

Product Description: Cytomid 250 Tablet contains Flutamide, an anti-androgen medication used in the treatment of prostate cancer. It works by blocking the action of male hormones (androgens) that promote the growth of cancer cells in the prostate gland, thereby slowing disease progression

Product Name: Calutide 50 Tablet

Brand Name: Calutide, Casodex, Bicalutide

Composition: Bicalutamide (50mg)

Manufacturer/Marketer: Cipla Ltd

Packaging: To be provided (specify packaging details if available)

Treatment: Prostate cancer

Product Description: Calutide 50 Tablet contains Bicalutamide, an anti-androgen medication used in the treatment of prostate cancer. It works by blocking the action of male hormones (androgens) that promote the growth of cancer cells, slowing the progression of the disease

Product Name: Pazinib 400mg Tablet

Brand Name: Pazinib, Votrient, Pazocip

Composition: Pazopanib (400mg)

Manufacturer/Marketer: Hetero Healthcare Limited

Packaging: To be provided (specify packaging details if available)

Treatment: Renal cell carcinoma (kidney cancer), advanced soft tissue sarcoma

Product Description: Pazinib 400mg Tablet contains Pazopanib, a tyrosine kinase inhibitor used in the treatment of advanced kidney cancer (renal cell carcinoma) and certain types of soft tissue sarcoma. It works by inhibiting the growth of cancer cells by blocking specific enzymes required for tumor growth and blood supply

Gefitinib Tablet is an anti-cancer medicine. It contains 30 Tablets per bottle. Formulated under the supervision of medical experts, Available in temper-proof packaging, our products are thoroughly tested by medical experts to ensure zero impurity.Gefitinib tablets are indicated as monotherapy for the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of both platinum-based and chemotherapies.

Features:

• Effective
• Accurately composed
• Hygienically prepared and packed

Dosage:

• Available as 250mg tablets

Overdose:

• Symptoms like diarrhea and rash

Precautions & Warnings:

• Should not be taken without consulting the doctor if the patient ever had pulmonary fibrosis (scarring of the lungs), or liver or kidney disease
• Not recommended if the patient is allergic to the medicine or any of its constituents
• Kindly notify the doctor immediately, if allergic reactions (difficulty breathing, closing of the throat, swelling of the lips, tongue, or face; or hives), lung problems, liver problems, eye problems, severe nausea, vomiting, loss of appetite, or diarrhea during treatment are noticed
• Doctor consultation recommended for pregnant women or for those who are breast feeding their child

Pomalid 1/2/4 mg Capsule:

• Brand Names: Pomalid, Pomalyst, Pomalong
• Composition: Pomalidomide (1mg, 2mg, or 4mg)
• Manufacturer/Marketer: Natco Pharma Ltd
• Packaging: Box of 21 capsules
• Treatment: Used for the treatment of multiple myeloma (a type of blood cancer) and other conditions related to cancer.

Product Description:
Pomalid contains Pomalidomide, which is an immunomodulatory agent that helps slow down the growth of cancer cells and boosts the immune system to attack cancer. It is commonly used in patients with multiple myeloma who have not responded well to other treatments.

Popular alternatives to Pomalid include Pomalyst and Pomalong

• Breast cancer
• Cancer of colon and rectum

• In Breast cancerCapetero 500mg Tablet helps to treat breast cancer and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Capetero 500mg Tablet kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.In Cancer of colon and rectumCancer of the colon and rectum, also known as colorectal cancer (CRC) or bowel cancer, is the development of cancer from two parts of the large intestine, namely, the colon or rectum. In this type of cancer, the person may notice symptoms such as blood in the stool, a change in bowel movements, weight loss, and fatigue. Capetero 500mg Tablet treats and also lowers the risk of developing further cancerous growths (polyps) and bowel cancer. It kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective, yet very toxic medicine and you should discuss the risks and benefits with your doctor. Avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated.

Nubeqa 300mg tablet consists of the active ingredient Darolutamide. It is an androgen receptor inhibitor used for treating adult men with non-metastatic castration-resistant prostate cancer. It is also approved to treat hormone-sensitive metastatic prostate cancer in combination with other anti-cancer medications. Prostate cancer occurs when the prostate cells start multiplying and dividing abnormally. Do not take this medicine if you are allergic to darolutamide or any other ingredient in it.    

Effective contraception is to be taken while using Nubeqa 300mg Tablet, and it must be continued till one week after the last dose with this medication to prevent pregnancy. Before starting treatment with this medication, inform your doctor if you have any liver problems, kidney problems, heart conditions, or allergic conditions.  

Nubeqa 300mg tablet may cause infertility in men, hence discuss your fertility concerns with your doctor before beginning treatment with this medication. Inform your doctor if you are lactose intolerant before starting treatment with this medication, as it contains lactose. Fatigue, rash, and pain in muscle, bone, arms, and legs are common side effects of this medication. 

• Non-metastatic, castration-resistant prostate cancer (prostate cancer that hasn’t spread to other body parts and does not respond to medicinal or surgical treatment)
• Hormone-sensitive metastatic prostate cancer in combination with other anti-cancer medications.

Therapeutic Effects of Nubeqa 300mg Tablet

Nubeqa 300mg tablet works by inhibiting the activity of androgens (testosterone) which are male sex hormones. Inhibition of these hormones stops the growth, division and multiplication of cancer cells. 

Inform your doctor about any prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products that you are taking or have taken before the treatment. Certain medicines may interact with Nubeqa 300mg tablet and can cause undesirable side effects. 

• Keep Darolutamide out of sight and reach of children.
• This medication is to be stored at or below 30 °C.
• If you missed your regular dose, take it as soon as you remember. If it is 2 hours or less before your next dose, do not take the missed dose.  Inform your physician about the missed dose. Do not take 2 doses at the same time.

Nubeqa 300mg tablet is to be taken exactly as prescribed by your healthcare provider. Swallow this medication whole with food and water. The frequency of administration will be decided by your doctor based on the severity. 

Alfoo 10mg (Alfuzosin 10mg) Tablet:

• Brand Names: Alfoo, Xatral (Alfuzosin is widely known by these names)
• Composition: Alfuzosin 10mg
• Strength: 10mg
• Manufacturer: Cipla Ltd.
• Packaging: 10 tablets per strip
• Treatment: Used for the treatment of benign prostatic hyperplasia (BPH).

Product Description: Alfoo 10mg contains Alfuzosin 10mg, an alpha-blocker used to treat symptoms of benign prostatic hyperplasia (BPH), a condition in which the prostate gland is enlarged in men, causing difficulty in urination. Alfuzosin works by relaxing the muscles in the prostate and the bladder neck, making it easier to urinate and improving urine flow.

This medication is typically prescribed for men who have BPH, which can cause symptoms like frequent urination, a weak stream, or an inability to empty the bladder completely. Alfuzosin helps relieve these symptoms but does not shrink the prostate or prevent its further enlargement.

Common side effects of Alfoo 10mg include dizziness, headache, fatigue, or fainting, especially when standing up quickly (orthostatic hypotension). It is advised to rise slowly from a sitting or lying position to minimize the risk of dizziness.

Patients are recommended to take this medication as prescribed, usually once daily after a meal. Alfoo 10mg should not be taken on an empty stomach. It is also important to follow up with the doctor regularly to monitor the effectiveness of the treatment and adjust the dosage if necessary.

This medication may interact with other drugs, so it is important to inform the doctor of all other medications being taken. Additionally, Alfoo should be used with caution in individuals with a history of heart problems, and it is not suitable for use in women or children.

Brand Names: Anaridex, Arimidex

Composition: Anastrozole

Strength: Available in 1 mg tablets

Manufacturer: Healing Pharma.

Packaging: Blister packs of 10 tablets

Treatment: Breast cancer in postmenopausal women

Product Description:
Anaridex (Anastrozole) is a potent aromatase inhibitor used to treat hormone receptor-positive breast cancer in postmenopausal women. By lowering estrogen levels, Anastrozole helps slow down or stop the growth of cancer cells that rely on estrogen to grow.

Indications:

• Hormone receptor-positive breast cancer in postmenopausal women
• Adjuvant treatment of early breast cancer
• Treatment of advanced breast cancer

Dosage and Administration:
Typically, Anaridex is taken once daily, with or without food, as prescribed by a healthcare provider. The standard dose is 1 mg per day.

Common side effects include:

• Hot flashes
• Fatigue
• Joint pain
• Osteoporosis

Packaging:
Anaridex is available in blister packs containing 10 tablets each.